moxifloxacin

(redirected from Moxifloxacin hydrochloride)
Also found in: Medical.

mox·i·flox·a·cin

 (mŏk′sĭ-flŏk′sə-sĭn)
n.
An antibiotic drug of the fluoroquinolone class, C21H24FN3O4, used primarily to treat respiratory, sinus, and skin infections.

[m(eth)- + alteration of oxy- + -floxacin, fluoroquinolone suff.; see ciprofloxacin.]
Translations

moxifloxacin

n moxifloxacino, moxifloxacina
References in periodicals archive ?
Tenders invited for Eye drop, brimonidine tartrate & eye drop moxifloxacin hydrochloride
M2 EQUITYBITES-October 6, 2017-Mylan introduces Moxifloxacin Hydrochloride in 0.
In an advisory, the FDA said these unregistered drug products are Moxifloxacin Hydrochloride (Moxibright) 5 mL Eye Drops, Moxifloxacin Hydrochloride + Dexamethasone Sodium Phosphate (Moxibright DM) 5 mL Eye Drops, Carboxymethyl Cellulose Sodium + Glycerin (Tearbright Plus) 10 mL Eye Drops, Gatifloxacin + Prednisolone Acetate (Gatsun-P) 5 mL Eye Drops and Moxifloxacin Hydrochloride (Occumox) 5 mL Eye Drops.
Reddy's reports market availibility of US FDA approved Moxifloxacin Hydrochloride Tablets 400 mg
A validated RP-HPLC method for the analysis of moxifloxacin hydrochloride in pharmaceutical dosage forms.
Product name: Avelox(R) Tablet 400mg Generic name: Moxifloxacin hydrochloride Acquisition of import approval: October 11, 2005 NHI drug price listing: December 9, 2005 Date of market launch: December 9, 2005 Main characteristics: Expected to have significant clinical efficacy as a respiratory quinolone because of its excellent antibacterial effect on all the major bacterial causes of respiratory tract infections and good migration to all tissues in the respiratory tract.